Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Stable hemoglobin in hemodialysis patients: forest for the trees--a 12-week pilot observational study.

Rottembourg JB, Kpade F, Tebibel F, Dansaert A, Chenuc G.

BMC Nephrol. 2013 Nov 4;14:243. doi: 10.1186/1471-2369-14-243.

2.

[Feasibility strategy of darbepoetin alfa administration every other week: 2005-2007 experience in a dialysis unit].

Rottembourg JB, Dansaert A.

Nephrol Ther. 2011 Dec;7(7):549-57. doi: 10.1016/j.nephro.2011.03.011. Epub 2011 May 31. French.

PMID:
21622039
3.

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

Feriani M, De Meester JM, McMahon LP, Rottembourg JB, Bridges I, Farouk M, Pronai W.

BMC Nephrol. 2011 Mar 24;12:13. doi: 10.1186/1471-2369-12-13.

4.

An observational study of the effectiveness of darbepoetin alpha administered in dialysis patients once every 2 weeks for 12 months.

Rottembourg JB, Bridges I, Pronai W, Feriani M, McMahon LP, De Meester JM, Farouk M, Molemans B.

Clin Nephrol. 2011 Mar;75(3):242-50.

PMID:
21329635
5.

Thrombocytopenia induced by nicotinamide in hemodialysis patients.

Rottembourg JB, Launay-Vacher V, Massard J.

Kidney Int. 2005 Dec;68(6):2911-2. No abstract available.

PMID:
16316377
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk